{{Rsnum
|rsid=1934967
|Gene=CYP2C9
|Chromosome=10
|position=96741426
|Orientation=plus
|GMAF=0.1961
|Gene_s=CYP2C9
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 57.5 | 37.2 | 5.3
| HCB | 65.7 | 32.1 | 2.2
| JPT | 61.9 | 31.9 | 6.2
| YRI | 96.6 | 3.4 | 0.0
| ASW | 77.2 | 22.8 | 0.0
| CHB | 65.7 | 32.1 | 2.2
| CHD | 70.6 | 27.5 | 1.8
| GIH | 57.4 | 35.6 | 6.9
| LWK | 92.7 | 7.3 | 0.0
| MEX | 36.2 | 46.6 | 17.2
| MKK | 91.0 | 9.0 | 0.0
| TSI | 69.6 | 26.5 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22321278
|Title=[Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy]
}}

{{PMID Auto
|PMID=22178823
|Title=[Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}